On Wednesday, shares of Mercury EV-Tech Ltd hit a 5 per cent upper circuit to Rs 94.54 per share from its previous closing of ...

Brookfield Infrastructure Partners L.P. closed C$4.78 below its 52-week high of C$50.46, which the company achieved on October 28th.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Recombinant pertussis booster vaccines provided sustained immunity against whooping cough in adolescents and young adults, ...

Fintel reports that on December 23, 2024, William Blair downgraded their outlook for Applied Therapeutics (NasdaqGM:APLT) ...

At 52 weeks, there was no significant difference in clinical remission ... and significantly lower for patients on ...

Concizumab is a tissue factor pathway inhibitor antagonist that enhances factor Xa production during the initiation phase of coagulation. This production improves thrombin generation and clot ...

Therapies for EBV-positive posttransplant lymphoproliferative disease, breast cancer, Barth syndrome, pain, and migraine are under review.

Using the X-shooter instrument at ESO's Very Large Telescope (VLT), German astronomers have detected three new pre-white ...

But similar to Season 1, another player is operating with an ulterior motive, and they happen to wear the number 001. So, who ...

Lichen China Ltd. Class A ( (LICN) ) just unveiled an update.

AM(IST)on Wednesday in an upbeat market. Torrent Pharmaceuticals Ltd.(up 1.0 per cent), Natco Pharma Ltd.(up 0.88 per cent), ...